Groundbreaking immunotherapy could finally treat devastating childhood brain tumors
A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — diffuse midline gliomas.
A groundbreaking immunotherapy is showing unprecedented success against one of the deadliest childhood brain cancers — diffuse midline gliomas.
It’s mRNA-based, the same technology Moderna used for its Covid-19 vaccine.
Scientists added peanut-protein to a toothpaste and tested it on adults with peanut allergies. Here's what happened next.
The clinical benefits are astonishing in some cases.
This is truly an exciting achievement.
The results are huge.